Onko-Sure is the first FDA cleared blood test for colorectal cancer since CEA, the current standard of care lab test. As part of an effective post-surgery treatment plan, Onko-Sure adds true clinical value for monitoring CRC patients with low CEA values. In fact, there is a considerable amount of scientific literature supporting the case for Onko-Sure and its demonstrated value as a monitoring strategy for post-diagnosis CRC within the United States.
You may find it helpful to hear the comments of one of the most prominent CRC surgeons regarding Onko-Sure and his experience with Onko-Sure in his practice:
Downloadable Literature:
- Wu_J Immunoassay_1998
- Wu_Shanghai J Lab Med_2001
- Kerber_Aliment Pharmacol Ther_2004
- Rucker_Anal Lett_2004
- Lee_Immune Network_2006
- Hundt_Cancer Epidemiol Biomarkers Prev_2007
- Small-Howard_J Immunoassay Immunochemistry_2010
- Shimwill_Caner Biomark_2010
- Cordero_World J Clin Oncol_2011
For more information about Onko-Sure, please contact us direct at info@radient-pharma.com or call us at (714) 505-4461.